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Recent estimates of human requirement for indispensable amino acids have shown that the requirement for key
amino acids such as lysine is twofold–threefold higher than previously thought. As a consequence recommended
intakes for protein, particularly for vulnerable groups such as the elderly, need to be revised. Indispensable
amino acids can also be used directly to improve amino acid supply in diets. A range of nitrogen compounds
such as creatine and branched chain amino acids are currently used by groups such as athletes, although their
efficacy is open to question. Peptides are natural components of the diet and some of these have been shown to
have beneficial effects. The emergence of methods for genetic modification of food proteins raises possibilities
of the development of novel foods for a variety of benefits including improved supply of indispensable amino
acids, reduced allergenicity, or preformed antibodies to reduce risk of disease.
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Introduction
With the rapid development of biological technologies
affecting plant and animal reproduction and growth, as well
as food technologies creating new methods for processing
food components, there exist many avenues for the develop-
ment of novel foods. But there is also the possibility of
altering foods in such a way that there is either loss of
nutritional quality or even the introduction into processed
foods of components that have adverse effects on health. It
is essential that agricultural and food technologists under-
stand the implications of innovations in food production,
processing and formulation. Foods contain a very large
number of different proteins as well as peptides and amino
acids, and there are many ways in which alterations in these
components can alter the nutritional value or safety of a
food.
Protein metabolism and nutrition
Metabolism of protein and amino acids is now well under-
stood. All body proteins are in a continuous cycle of
breakdown and resynthesis (turnover), with widely varying
half-lives from a few minutes in the case of some enzymes
to approximately a year for connective tissues. Cells contain
a pool of amino acids that are drawn on for protein synthesis
and added to by protein breakdown. Whole cells also die and
the constituent proteins are broken down to contribute to the
extracellular and intracellular amino acid pools. Protein
synthesis is dependent on the availability of all 20 ‘standard’
amino acids in the cytoplasm. Of the 20 amino acids, 10 are
essential or indispensable and must be supplied in the diet.
The remaining 10 are able to be synthesized by transfer of an
amino group to the appropriate metabolic intermediate. Total
absence of protein (or indispensable amino acids, IAA) from
the diet does not block protein synthesis because amino acids
are continually supplied into the intracellular pool by break-
down (turnover) of body proteins. Total protein synthesis
approximates 250–350 g per day in the adult, while dietary
protein intake is usually around 80–110 g per day. Dietary
protein is therefore ‘topping up’ the pool of amino acids,
which feeds into protein synthesis.
Many of the proteins and peptides in food could have
untoward pharmacological or toxic effects in the body if they
entered the blood stream but the body is mostly protected by
the cell membranes of the gut wall and the digestive
enzymes, which break down protein and peptides in the gut.
The end-products of protein digestion by the pancreatic
enzymes include a proportion of free amino acids, with the
major part left as short chain peptides having up to six or so
amino acid residues. These amino acids and short chain
peptides diffuse through the mucous layer overlying the villi,
and come into contact with the brush border membrane that
carries transport proteins for the uptake of amino acids.
There are two general routes of uptake of amino acids from
the gut lumen into the epithelial cells: one for free amino
acids and a second for di- and tripeptides. The brush border
membrane holds peptidase enzymes on its external mem-
brane. A proportion of the short chain peptides is hydrolysed
to single amino acids. Active transport proteins for the amino
acids are in close proximity to the peptidase enzymes. A
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second system for the uptake of amino acids involves the
transport of di- and tripeptides. Once absorbed, most of the
di- and tripeptides are hydrolysed inside the epithelial cells
and diffuse into the portal blood as single amino acids.
Amino acid transport is specific for the L stereoisomers of
the amino acids, but the diet also contains small amounts of
D-amino acids, mostly from digested bacteria and derived
from fermented foods such as cheese and yoghurt. These
D-amino acids are taken up relatively slowly by diffusion.
They cannot be used in protein synthesis, with the exception
of D-methionine, which can be converted to L-methionine.
The D-amino acids are mostly degraded by a D-amino acid
oxidase in the kidney.
Although the activities of the pancreatic proteolytic
enzymes result in most of the dietary protein being digested,
a small fraction escapes digestion and very small amounts of
peptides and whole proteins are absorbed into the body.
Absorption probably occurs by diffusion through the para-
cellular pathway. Neonates take up significant amounts of
protein, particularly antibodies, from colostrum, probably by
pinocytosis.
Protein requirement and protein quality.
Adequate protein nutrition depends on two factors: (i) suffi-
cient protein in the diet, including sufficient metabolisable
nitrogen; and (ii) satisfactory protein quality in terms of the
amount of IAA in the protein. Protein requirement has been
determined predominantly from nitrogen balance studies.1
Nitrogen balance studies, usually carried out on young
healthy adults, have indicated an average requirement of
approximately 0.625 g/kg per day for high-quality protein.
The recommended intake is derived from this figure by
adding 25% (two times the estimated standard deviation) to
cover the requirement of almost all of the population, giving
a recommended intake of 0.75 g/kg per day for high-quality
protein.2 The US RDI is set at 0.8 g/kg per day, allowing for
the average quality of dietary protein being a little less than
that of the highest nutritional quality proteins (eggs, milk and
meat). There could be a further adjustment upwards if the
RDI was to be applicable to diets of lower quality and
digestibility, as for vegetarians or for populations consuming
relatively high intakes of cereal staples, as in some develop-
ing countries.
There are two sources of uncertainty in relation to adult
protein and amino acid requirement and recommended
intake; the first is that the definition of protein requirement
may not be optimum; and second, there is uncertainty
regarding the requirement for individual IAA. The estim-
ation of protein requirement is based on determining the
amount of dietary protein that will just maintain nitrogen
balance. However, there is no firm basis for the assumption
that maintenance of nitrogen balance is satisfactory in terms
of maintaining optimum human health.3 In fact adaptation to
low protein intake certainly occurs. Chronically low intakes
of protein (and energy) bring about a reduction in body-
weight and cell mass. The rates of protein synthesis and
breakdown both decline. The IAA are more efficiently
recycled and the N-balance can be re-established after some
time at a lower protein intake.4 The reduction in body protein
(muscle and internal organ mass) is almost certainly not
desirable, and it is likely that there are other tests of physio-
logical function, for example, maintenance of optimum
immune function that would result in a higher estimate of
requirement than that given by N-balance studies.
For infants and children, recommended intakes are based
on estimates of normal intakes compatible with optimum
growth rate. In recent years research using stable isotopes
has allowed more accurate measurement of intakes of breast
milk by healthy infants, and it appears that earlier estimates
of breast milk intake were high and it is now considered that
the estimated requirement for protein can be reduced from
120 mg N/kg per day to 90 mg N/kg per day.5
In the case of the elderly, it has been suggested that the
current RDI is too low. Moreover, as people age, energy
expenditure is reduced and there is a loss of lean body mass.
With the reduction in energy expenditure there is a conse-
quent lower energy intake, and assuming that protein makes
up the usual 12–16% of energy, protein intake is also likely
to be low. In the USA it was found that 10–25% of women
over 55 years of age had protein intakes less than 30 g per
day.6 It is recognized that elderly people can adapt to a low
protein intake but this may involve (i) further loss of lean
mass; and (ii) reduction in functional capacities such as
immune competence.4 Campbell and Evans reviewed studies
on protein requirements of the elderly and calculated a
requirement of 0.9 g/kg per day,7 which, with an appropriate
safety margin, would lead to a recommended safe and
adequate intake for high-quality protein of 1.0 g/kg per day.
Estimated protein requirement and recommended intake are
specified in relation of kilograms of bodyweight. Yet body
composition varies widely in elderly people and there is a
lack of information on the effect of differences in body
composition on protein requirement. The United Nations
Food and Agriculture Organization (FAO) is initiating a
review of current estimates of protein requirement and RDI.5
There has been much discussion regarding the protein
requirement of sports players in a variety of sports, and there
is a commonly held view that high intakes of protein are
beneficial for athletes endeavouring to increase muscle mass
and strength. In fact the high energy expenditure involved in
training and playing sport generally results in a higher intake
of food energy, with the consequence that intake of protein
is usually high in relation to bodyweight anyway. High
intakes of protein do not increase muscle mass if not
accompanied by appropriate physical training but relatively
high intakes, approximately 1.5 g/kg per day, in combination
with appropriate strength training does assist gain of muscle
mass. The current consensus is that intakes in the range of
1.2–1.6 g/kg per day should be adequate for all sports
players.8,9
It is important to note that adequacy of protein supply
depends on adequacy of energy supply, and under circum-
stances where energy intake is inadequate, both the amino
acids from dietary protein and amino acids liberated by body
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protein turnover are substantially diverted to energy produc-
tion through gluconeogenesis. There is little point therefore
in taking action to improve protein input if total energy
intake is inadequate. Protein–energy malnutrition in children
is a major problem in developing countries. The aetiology of
this condition is complex, usually involving early cessation
of breast-feeding, frequent infections and chronic intestinal
infestation, use of inappropriate weaning foods that may
have a low energy and protein density, lack of knowledge on
the part of parents and overall family and community
poverty. Although most of the possible remedial actions are
outside the scope of this paper, two related factors should be
mentioned: first, education of parents; and second, use of
appropriate weaning foods. Young children have high meta-
bolic rates per kg bodyweight compared to adults, and
coupled with this is the generally small volume of food that
such children can consume at a meal. As a consequence it is
important to educate parents about the needs of young
children for richer foods that deliver the required energy and
protein in a small volume. There are many programmes
around the world working to develop and supply appropriate
weaning foods. There are, as well, many opportunities for
the further development of novel food products in this area;
foods that are energy- and protein-dense, readily digestible,
affordable, with good keeping qualities, and culturally
acceptable.
Determinants of protein quality
The nutritional value of dietary protein depends on adequacy
of supply of each of the indispensable amino acids in relation
to the specific requirement. Thus any food treatment process
that affects any of the 10 indispensable amino acids has the
potential to reduce nutritional value. In practice a relatively
small number of amino acids are of practical importance in
determining protein quality in overall diets. The amino acids
that are most often limiting in staple foods, and therefore
effectively determine the nutritional quality of food proteins,
are lysine (in cereal protein), methionine (in legumes),
tryptophan (in corn) and threonine, together with lysine (in
rice). Any process that affects the level of any of these amino
acids in foods has the potential to adversely affect protein
quality in general diets.
Lysine is of greatest importance because it is the most
limiting amino acid in cereal diets that are staples in most
parts of the world. There is still some doubt, however,
regarding human requirement for lysine. The studies of Rose
and others in determining requirements for individual amino
acids using maintenance of nitrogen balance in adults as the
criterion of requirement, provided the basis of the FAO/
WHO summary of requirements for specific amino
acids.10,11 But more recent studies have led to a reassessment
of amino acid requirements, as summarized in Table 1.
Young et al. at the Massachusetts Institute of Technology
(MIT) drew attention to the marked difference between the
estimated IAA requirements of adults, based on N-balance,
and those of children, based on intakes that support
maximum growth rate.12 Suspecting that the estimated
requirements of adults were low, they developed a new
method for determining IAA requirement based on rates of
oxidation of isotopically labelled IAA in experimental sub-
jects (tracer balance method). The requirement for several
key IAA determined by this method were found to be two to
three times higher than those previously reported,11 and were
closer to, though still less than, the requirements estimated
for infants and children. Comparison of estimated lysine
supply in usual third world diets with the requirement
determined by Young et al. suggested that lysine intake
would commonly be deficient. However, as with protein,
there is adaptation to low intakes of IAA. Millward et al.
have shown that adaptation to low intakes of lysine does
occur and that this is probably important in third world
environments with major dependence on cereal proteins.13
The research of Millward et al. also using rates of oxidation
of labelled IAA indicates a lysine requirement for adults of
23.2 ± 2 mg/kg per day for adults adapted to a low lysine
diet. This is approximately twice the earlier estimate11 and
approximately 20% below that of Young and El-Khoury.14
Although the question of requirement for lysine is not fully
resolved, there is now a shift towards acceptance of the MIT
values as being the best estimate of adult IAA requirement.
The question of IAA requirement and supply is important
because it is the basis for estimating protein quality. Lysine
is particularly important because on a worldwide basis it is
likely to be in shortest supply in relation to requirement and,
Table 1. Estimated indispensable amino acid requirements for children and adults (mg/kg per day)
Amino acid WHO1 Young & el-Koury14 Millward et al.13
Child 2–5 years Adult Adult Adult
Histidine ?   8–12† –
Leucine 73 14 39
Lysine 64 12 30 23.2 (adapted)
Methionine + Cys 27 13 15
Phenylalanine + Tyr 69 14 39
Threonine 37   7 15
Tryptophan 12   4 6
Valine 38 10 20
†Recommendation for histidine; although not based on definitive data.
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in addition, it is the IAA most susceptible to destruction in
food processing.
Amino acids
A number of amino acids are now produced in quantity by
fermentation. Lysine, for example, is produced relatively
cheaply in large quantities for improving the protein quality
of animal diets. There exist broad possibilities for the
addition of lysine as the free amino acid or in a peptide form
to novel food products in areas where lysine is commonly
deficient. Although the same logic applies to the other
indispensable amino acids, there is not the same wide-
ranging occurrence of low intakes as there is with regard to
lysine. When single amino acids are used in foods problems
of taste may have to be overcome but technologies are
available to handle this. There have been trials of the use of
lysine-fortified wheat flour in some areas. Zhao et al. report
increased serum transferrin and improved immunological
parameters in subjects consuming lysine-fortified wheat
flour over a 3-month period in a region of China where
wheat flour provides nearly two-thirds of the protein con-
sumed.15
High intakes of single or several amino acids already
occur in various situations. For example, soy sauce made by
fermentation of soy and wheat protein has a long history as
a flavour enhancer and contains high levels of glutamate as
the monosodium salt (MSG). High intakes of particular
amino acids can distort the normal amino acid profile in
blood and tissues and produce unwanted effects, at least in
some individuals. Some are susceptible to MSG and develop
a ‘Chinese restaurant syndrome’ characterized by headache,
flushing and dizziness. The systemic circulation is protected
to a large extent from exposure to high levels of glutamate
because of the high extraction rate of glutamate and
glutamine in the first pass through the splanchnic bed (gut
and liver), close to 90% being removed, that being the
highest extraction rate of all of the amino acids. However,
given the key role of glutamate and glutamine in amino acid
metabolism and in neurotransmitter function it is not surpris-
ing that excessive dietary intake could evoke a reaction in
some people. Similarly tyramine, decarboxylated tyrosine,
formed in fermented foods can provoke neurological reac-
tions such as migraine in susceptible individuals.
Athletes, particularly weightlifters and body builders,
have a reputation for trying almost any substance they
believe may give them an advantage in their sport. Liquid
and powder protein formulations are widely used despite the
fact that high biological value food proteins (meat and dairy
products) are as effective and much less expensive. Various
amino acid preparations are also used. Glutamine and
branched chain amino acids (BCAA) are popular at the
present time. The BCAA (leucine, isoleucine and valine) are
the only indispensable amino acids metabolized in peripheral
tissues rather than the liver. The BCAA breakdown occurs in
muscle, and the enzymes for the first two steps in the
breakdown pathway are common to the three amino acids.
There is a general view that the BCAA are ‘anabolic’,
stimulating muscle hypertrophy, hence their attraction for
athletes wanting to add muscle bulk. But there has been
mixed evidence as to the efficacy of BCAA in aiding muscle
gain or work output. The BCAA do not seem to be an
important fuel for muscles, and even in prolonged exercise
BCAA concentrations in muscle do not change to a signifi-
cant degree. The BCAA have also been claimed to reduce
fatigue in athletes on the basis that BCAA reduce the uptake
of tryptophan into the brain by competition for a common
transport mechanism, thus reducing the rate of formation of
serotonin, which is suggested to be the mediator of central
fatigue. But taking BCAA prior to exercise has shown no
beneficial effect in reducing fatigue.8,9,16
Various combinations of free amino acids have been used
by athletes to try to enhance endogenous production of
growth hormone, including arginine, ornithine, lysine and
tyrosine, but experimental studies have not been able to
show any stimulatory effect.17 Tryptophan has been used
by athletes and in alternative medicine for a range of
conditions including sleep disturbance, anxiety and
Tourette’s syndrome. Tryptophan is a precursor of serotonin
(5-OH-tryptamine), a neurotransmitter that is involved in a
variety of functions including sleep rhythm, pain perception
etc. α-lactalbumin in milk is relatively rich in tryptophan,
which may explain the anecdotal association of a milk drink
before bed with better sleep. The role of tryptophan in
nutrition has been reviewed by Heine et al.18 Following an
outbreak of a condition called eosinophillia–myalgia syn-
drome (EMS) associated with tryptophan usage in the USA in
1989, the availability of tryptophan was restricted to prescrip-
tion only. Eosinophillia–myalgia syndrome involves accumu-
lation of eosinophils in tissues, muscle and joint pains,
neurological manifestations, and a number of deaths were
recorded. It appears that the condition may have been caused
by a tryptophan dimer in the tryptophan preparations used but
this is still uncertain. This experience argues for considerable
caution in experimentation with new preparations of what
may be thought to be normal food molecules.19
Creatine is an amino acid for which the function is to
maintain an energy reserve in muscle as creatine phosphate,
recharging adenosine triphosphate (ATP) as energy is used
in muscle contraction. The amount of creatine phosphate in
muscle provides sufficient energy reserve to support vigor-
ous muscle contraction for only 10–20 s. It has a key role,
however, in short duration sports events where explosive
muscle power is required as in sprints, jumps, and throws.
Creatine is synthesized in the body and is obtained naturally
in the diet as a component of meat. In recent years athletes
have taken to using supplements of creatine and these have
been shown to be effective in raising the concentration of
muscle creatine phosphate. Because of the natural variation
in individual sports performance it is difficult to show
statistically significant improvements in performance in
response to treatments such as the taking of supplements.
However a number of studies have shown improvement in
performance for short events, and it appears likely that it is
effective, but to what degree and for which events is less
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certain. Creatine intake causes an increase in weight, which
is mainly a result of retention of water in muscle, but may be
due in part to a gain in muscle protein. Creatine is now one
of the most popular dietary supplements used by athletes and
body builders, some taking more than 50 g per day. There
appear to be no adverse affects as a result of consuming high
intakes of creatine in the short term but the long-term safety
is less certain. Questions have been raised regarding possible
deterioration in renal function but there is little firm evidence
as yet.
Peptides
Many peptides and peptide derivatives have key roles in
regulating internal physiological processes, functioning as
hormones, neurotransmitters etc. It might be assumed that
peptides in food or derived by digestion of protein in food
would not have biological effects within the body because
the internal environment is protected by the gastrointestinal
membrane barrier and the powerful protein digestive
enzymes of the stomach and pancreas. Although this is
largely so, it has been shown that small amounts of protein
and peptides are able to enter the circulation intact.20 Protein
digestion in the gut produces a very large number of peptides
and many of these could have potential biological effects. It
has been found that at least some peptides, taken orally or
formed within the gut, can have physiological effects.
Whether this is a response to absorbed peptide or a response
to a peptide activating a receptor in the lumenal membrane is
not always clear. Peptides and proteins do cross the gut wall
to enter the circulation but only in very small amounts,
detectable by sensitive radioimmunosorbent assays. Entry is
apparently by diffusion through the intercellular junctions of
the villous epithelium, entering the blood stream via the
lymphatics. Disturbance of the integrity of the intestinal wall
as in inflammatory disease (e.g. coeliac disease) or following
the taking of alcohol or drugs such as indomethacin,
increases the permeability of the intestine to larger mole-
cules and is likely to increase the possibility of systemic
response to peptides formed in the lumen.20
As an example, it was demonstrated that luteinizing
hormone-releasing hormone given to rats orally resulted in a
dose-dependent release of luteinizing hormone into the
blood, showing that administration into the gut provoked a
systemic response.21 Peptides that are active in the gut are
commonly modified (blocked) at one or both ends with
groups such as a pyrollidone group at the N-terminal end
and/or amidation at the C-terminal end. Blocking of the end
groups may influence biological activity and/or increase
resistance to hydrolysis by peptidases. Brantl et al. fraction-
ated active peptides from casein peptone, a tryptic digest of
casein, and identified a casomorphin thought to be an agonist
for the µ-type opiate receptors,22 which appear to predom-
inate in the gut, raising the possibility that such caso-
morphins (exorphins) could modulate gut function.23
A number of bioactive peptides have now been identified
in mammalian and microbial enzyme digests of milk pro-
teins. Peptides formed by digestion of milk protein that exert
an antihypertensive action by inhibition of angiotensin-
converting enzyme (ACE inhibitors) have been studied in
some detail.24,25 Following the feeding of caseinomacro-
peptide to rats, fragments of the protein could be detected in
plasma by an immunosorbent assay. The immunoreactive
material peaked in the plasma at approximately 60 min after
feeding.26 There has been extensive study of ACE-inhibitory
peptides derived from bovine casein, and the major whey
fractions have also been shown to yield ACE inhibitors both
by hydrolysis with commercial enzymes and by fermentation
with cultures of lactic acid bacteria, which release extra-
cellular proteinases and endopeptidases by lysis.27
A cholesterol-reducing soy peptide (CSPHP) has been
manufactured which significantly decreases both low-
density lipoprotein (LDL)-cholesterol and total cholesterol
in plasma.28 The peptide was made by binding ‘enzymat-
ically decomposed’ lecithin to hydrolysed isolated soy
protein in the ratio of 80:20. Consumption of CSPHP at 3 g
per day decreased LDL-cholesterol by up to 27% in hyper-
cholesterolaemic patients after 3 months. The product is said
to have a suitable taste and texture for incorporation into a
wide range of food products.
Several peptides and peptide derivatives are used as
sweeteners in foods. Aspartame, for example, is an
L-aspartyl-L-phenylalanine methyl ester. Hydrolysis yields
aspartate and phenylalanine. The phenylalanine is of signifi-
cance to those with phenylketonuria and it is essential that
appropriate labelling is used so that consumers are informed.
Alitame is a related sweetener made up of an L-aspartate–D-
alanine tetramethylthietane yielding aspartate and D-alanine.
Glutathione (GSH), a tripeptide made up of glutamate,
cysteine, and glycine, offers considerable potential as a
dietary constituent. Glutathione is a modulator of immune
function, an antimicrobial and possibly an anticancer agent.
It is a key reducing agent within cells, and is maintained in
the reduced state by the reduced form of nicotinamide
adenine dinucleotide phosphate (NADPH) and in turn main-
tains ascorbic acid and vitamin E in their reduced forms. It
functions as a redox buffer and removes toxic peroxides
through the action of the enzyme glutathione peroxidase,
which contains selenocysteine.29 Benefits that have been
attributed to dietary proteins such as whey, which are
relatively high in methionine and cysteine, may have their
action by boosting the intracellular concentration of GSH.
Glutathione can now be produced in bulk in yeast cultures,
making it available as a food additive.30
Adverse reactions, allergy
Adverse reactions to particular foods may be experienced by
susceptible individuals and include food intolerance and
food allergy. Food allergy is mediated through the immune
system and involves initial exposure to an allergenic compo-
nent in the food, usually a glycoprotein, which elicits
formation of an allergen-specific IgE. The allergic response
occurs on subsequent exposure when absorbed allergen
binds to the allergen-specific IgE bound to the cell mem-
branes of mast cells and basophils, thereby provoking
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degranulation and release of histamine and eicosanoid hor-
mones, which results in a range of symptoms including
respiratory (wheezing, asthma), cutaneous (angio-oedema,
rash, hives), gastrointestinal (vomiting, diarrhoea), and,
rarely, anaphylactic shock, which can be life-threatening.
Overall prevalence of allergy is estimated to be less than 2%
in adults and up to 6% in children. Children frequently ‘grow
out’ of their food allergies. Although many foods have been
reported to evoke allergic reactions, most allergies (>90%)
are in response to one of eight foods (cow’s milk, eggs, fish,
crustaceans, wheat, peanuts, soybeans, and tree nuts).31 With
regard to peanuts, one of the most common and potent
allergenic foods, recent work has focused on identifying the
allergenic proteins and responsible genes with a view to
removing the specific allergen, thereby creating a non-
allergenic variety. Interestingly, parallel work to sequence a
peanut trypsin inhibitor revealed 93% and 95% homology
with two known peanut allergens.32,33 Screening of peanut
varieties has shown considerable variation in allergen con-
tent, suggesting that breeding and selection could reduce or
eliminate allergenicity.33 The key control for problems of
allergy and food intolerance is correct labelling of foods and
their ingredients so that susceptible consumers are alerted to
the possibility of a reaction. The US Food and Drug Admin-
istration (FDA) has established a programme of testing foods
for major allergens to ensure that ingredients that are com-
monly allergenic are correctly declared on food labels.
Coeliac disease is of particular significance because it is
a potentially severe condition that is relatively common in
Caucasian populations, occurring with a frequency of
approximately 1 in 2000. Coeliac disease is an autoimmune
response that arises from the formation of an antigenic
complex of a subfraction of the gluten protein of wheat and
related cereals with tissue transglutaminase. The result is a
chronic inflammatory response leading to atrophy of the
small intestinal mucosa. The villi become clubbed and
normal absorptive function is severely reduced, resulting in
malabsorption and diarrhoea. There is frequently loss of
weight accompanied by various vitamin and mineral defi-
ciencies. Coeliac disease is not curable but is managed by
strict exclusion of gluten from the diet. Sensitivity to gluten
varies widely; some individuals are extremely sensitive and
others much less so. In developed countries more and more
commercially manufactured gluten-free products are becom-
ing available in supermarkets. It is important that there is
adequate surveillance to ensure their gluten-free status.
Coeliac disease is rare in Asian and African populations.
Unfortunately there is some tendency to confuse coeliac
disease with allergy to wheat. Coeliac disease requires
careful diagnosis and strict exclusion of gluten from all
sources, whereas in allergy to wheat (which should also be
correctly diagnosed), wheat and wheat products can be
consumed up to the level of tolerance.
Cooking, processing and preservation
The cooking of food generally improves nutritional value by
increasing digestibility, as well as the attractiveness of taste
and texture. Moist food cooking softens coarse textures, aids
chewing and swallowing and increases access by digestive
enzymes. Simple food processing such as milling of grains
also assists digestion. Cooking with dry heat above 100°C
causes browning, which is the result of many complex
reactions in which compounds with pleasant flavours are
created. One of the more simple of these chemical reactions
is known as the Maillard reaction, in which the side-chain
amino group of lysine reacts with the reducing aldehyde
group of sugars such as glucose, maltose and lactose. A
cross-link is formed that results in the loss of lysine in the
food product. Because the cross-linking occurs at high
temperature (>100°C) it is the crust that is affected in bread-
type products whereas in biscuits or breakfast cereals, which
are baked right through at a high temperature, all of the
protein in the product may have a reduced biological value.
In general, caramelization reactions that create desirable
colour and flavour reduce the nutritional value of protein. As
temperatures rise above 100°C a great variety of products are
formed. Most of these complex browning product molecules
are not digested and absorbed, and are lost in the faeces.
It is pertinent to note here that it is desirable to retain at
least some use of biological measures of protein quality such
as rat growth studies (protein efficiency ratio, net protein
utilization etc.) because factors such as reduced digestibility
or toxicity are detected as well as reduction in protein
quality.
Smoking of food has a preservative action because
aldehydes in the smoke react with side-chain amino groups
in protein, cross-linking the molecules and preventing
microbial growth. But smoke also contains compounds
shown to be carcinogenic, thus the use of smoking as a
preservative should be discouraged. Salting of food for
preservation also has a long history of use, and functions by
reducing water activity. It is both safe and effective but it is
now recognized that the intake of salt needs to be kept
reasonably low because susceptible individuals are prone to
develop hypertension with continued high intake. The Food
and Nutrition Board committee has recommended that
intakes not exceed 6 g per day. But higher intakes may be
necessary where heavy workloads under hot conditions
result in high rates of sweat loss.
Crops, derived products and genetic manipulation
A large amount of research is being undertaken in crop
development, including both new varieties of the major
staple crops as well as lesser known plant species. Soy is
one of the major crops in Western countries and has a long
history of use in the East. It is an excellent source of
protein. The raw seed of a typical variety has approx-
imately one-third protein and one-third carbohydrate, and
is, as well, a rich source of oil (15–20%). The nutritional
value of the protein is complementary to that of cereals in
that the higher lysine content makes good the relatively low
lysine content of wheat. The importance of this comple-
mentary effect should not be underestimated. This is
illustrated by considering as an example soy flour (full fat)
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and whole meal wheat flour. Because soy flour is high in
protein (37%), having a relatively high lysine content, an
admixture of only 20% soy flour into wheat flour increases
the protein content from 13% to 17.8% and more than
doubles the lysine content from 340 mg/100 g to 750 mg/
100 g. In the wealthier Western countries, lysine require-
ments are likely to be met by consuming high-protein
animal products whereas in developing countries with
greater population pressure and less land resources per
head of population, it will be more efficient in terms of
resources to increase protein and lysine intake by increas-
ing the use of legumes such as soy.
Some of the legumes are coarse in texture and less
attractive as food, but food technologists are putting a great
deal of effort into developing novel food formulations for a
wide range of products including meat alternatives and
extenders, soy milks and soy milk powder, soy-based yogurt,
non-dairy cheese, frozen desserts, candy bars etc. In the USA
and Europe these products are being developed to capitalize
on consumer sentiment, which regards soy products as ‘very
healthy’,34 but a secondary factor is the reduction in the cost
of raw ingredients. Developing countries can make use of
these technologies to bring new foods to market that will
increase variety and interest as well as increasing lysine
intake. The potential down-side of these developments is that
soy-based meat and dairy alternatives do not provide other
key nutrients such as iron, zinc and calcium, so it is still
important to increase production and use of animal products,
particularly for children.
Genetically modified organisms are coming into the food
supply at an increasing rate. The potential for developments
in crop plants with higher productivity, disease resistance,
frost and drought resistance, higher nutritional value etc.,
seem almost unlimited. Where a gene or genes are trans-
ferred between organisms, there are new proteins produced
in the target organism. The fact that the target plant or animal
is living is the first indicator that the rearranged genome and
its products as food are unlikely to be dangerous to health.
However, where a gene has been transferred with the express
purpose of creating a component toxic to an organism that
consumes the plant, it is obvious that testing must be
thorough. This is exemplified in the case of the StarLink
corn into which the Bt gene (Bacillus thuringiensis) was
transferred to make it toxic to the European corn borer. Basic
testing rules out overt toxicity but allergy remains possible,
and because the incidence may be very low it is virtually
impossible to rule it out in a prospective sense. For this
reason the FDA has approved Bt corn for use as animal feed
but has not approved it for human use. A major incident
occurred in 2000 when StarLink corn was detected in human
food and the manufacturer was ordered to recall the product.
Animal products
Animal production is enormously important in terms of
human protein supply. Animal products provide protein that
is almost always of high nutritional quality, with the notable
exception of gelatin (solublized collagen). Meat, including
fish, eggs, milk and milk products have sufficient of the
indispensable amino acids to improve the protein quality of
diets in which cereals, and other staples provide the bulk of
the energy but the protein quality is prejudiced by relatively
low lysine, threonine, tryptophan or methionine. The pro-
duction efficiency for animals is only approximately 10% of
that of plants in terms of energy and land area, but key
characteristics of animal products as food justify their posi-
tion in the food chain. These key characteristics include
(i) high energy and nutrient density; (ii) high digestibility;
(iii) supply of iron in haem form (more efficiently absorbed),
together with vitamin B12, calcium (milk and cheese), as
well as zinc, B6 etc.; (iv) production is not constrained by
seasonal availability; (v) the use by animals of vegetation
and vegetable products that cannot be used by humans
(grasses, shrubs); and (vi) the fact that animals can still
produce under semiarid conditions where cropping is not
possible.
The role of animal products is important in countering
protein–energy malnutrition in developing communities,
particularly in relation to children. Situations in which novel
foods based on animal products are likely to make a signif-
icant impact in developing countries is in improved process-
ing, packaging and preservation techniques. Animal
products spoil rapidly in hot climates and appropriate tech-
nologies will need to be inexpensive. Suitable preservation
will allow foods to be transported from production sites to
areas of demand, thus allowing development of a more
robust commercial food sector. New forms of packaging,
refrigeration, drying, pasteurization, water activity control,
fermentation and pickling may all be useful.
There are many new developments in agriculture that can
improve animal product supply in developing communities.
Some of these include farming of indigenous animals for
meat (e.g. deer in Africa), fish farming, adaptation of waste
products for animal feeds, cloning of animals to achieve a
rapid increase in high productivity breeding stock, genetic
modification of animals to achieve faster growth rates and
better feed conversion, as well as resistance to pests and
diseases. Of course the aforementioned must be achieved
with due respect to the well-being of animals and conser-
vation of the environment.
Milk products are a source of a diversity of protein
products, and this range is being extended by vigorous dairy
research. New formulations for milk, cheese, yoghurt and
related products are being developed for both Western and
Asian markets as well as more sophisticated fractionation of
milk to create proteins with special properties and uses.
Whey proteins have attracted attention because of their
solubility, digestibility and nutritional value. Whey proteins
are widely used in infant formulae and are more suitable than
casein for human infants. As well whey proteins appear to
have some advantageous properties such as stimulation of
immune function. The feeding of whey protein was shown to
reduce the incidence of tumours in rats injected subcutane-
ously with a procarcinogen. Liver glutathione, an anti-
oxidant and anticarcinogen, was higher in the livers of
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animals fed whey protein, which could have been due to the
higher content of methionine and cysteine.35
Simplesse® (CP Kelco, the Philippines) is a micropartic-
ulated whey protein concentrate. The microparticulated
structure of Simplesse® in foods provides a fat-like mouth
feel, allowing its substitution for fat and a reduction in
energy density in manufactured foods such as icecream.36
Lactoferrin, and iron-binding protein in mammalian
milk, which occurs at a relatively high level in normal breast
milk, is believed to have a role in non-specific defence
against pathogens. The tight sequestration of iron strongly
inhibits microbial growth and, as well, lactoferrin appears to
have antiviral and general stimulatory effects on the
immune system. Lactoferrin appears to offer large potential
as a food component, which will assist control of infections
without side-effects.37 Bovine immunoglobulins also appear
to have beneficial uses, particularly in milk for children.
Eggs from immunized hens may also be a useful source of
immunoglobulins38 and may be more effective than those
produced in cows.39 It is possible to immunize cows against
pathogens such as rotavirus, and the milk then contains
antirotavirus immunoglobulins, which are beneficial in over-
coming diarrhoeal disease in children.40,41 The immunoglob-
ulins at least partially survive in the human gastrointestinal
tract.42 Recent work is aimed at creating genetically modi-
fied (GM) cows that produce required proteins in their milk
as specified by the implanted gene.
One unexpected development in cattle production has
been the emergence of bovine spongiform encephalopathy
(BSE; TSE in the USA) a disease of the brain and nervous
tissue transmitted by a new infectious agent called a prion,
similar to scrapie in sheep, and kuru and Creutzfeldt–Jakob
dementia in humans. A prion is a particular protein found in
normal brain cell (neurone) membrane but which has a
different conformation (i.e. a different 3-D arrangement of
the peptide chains). The BSE prion was transmitted through
British cattle herds by the feeding of meat meal derived from
infected animals. The infective protein apparently acts by
entering the brain cell membranes of the newly infected
animal and catalyzing (?) the rearrangement of the normal
cell membrane protein into the prion form, which results in
the formation of vacuoles in the nerve tissue and leads to loss
of coordination and dementia. Human consumption of
infected nerve tissue can transmit the prion to humans,
initiating a dementia that is a variant of the Creutzfeldt–Jakob
type. The BSE prion is resistant to normal disinfection
processes and the spread of the disease has been stopped
only by slaughtering infected stock and prohibiting the
feeding of meat meal to other animals, as well as taking care
that none of the infected meat enters the human food chain.
The emergence of this disease has forced a detailed review
of regulations regarding appropriate feeds for animals des-
tined for meat production, as well as regulations to establish
tracking records for live animals, carcasses, and meat prod-
ucts. Meat industries set up in developing countries will be
forced to adopt sophisticated record and tracking systems if
they are to be involved in exporting meat products. Bovine
spongiform encephalopathy has initiated a shift away from
beef and sheep towards fish as sources of protein for food
technology use.
Techniques for transferring and manipulating genes in
animals are evolving, and a range of new GM animals are
being produced. There is, for example, an intense campaign in
Europe and the USA to map the genome of the pig with the
aim of opening up possibilities for genetic modification.
Sheep and cattle have been cloned and exogenous genes
implanted into pigs. One of the research directions has been to
manipulate growth hormone production in order to produce
animals that grow faster and attain greater size. The European
Union patent office recently granted a patent protecting a GM
salmon that grows up to eight times the size of the wild type.43
The USA FDA has announced that it intends to regulate the
use of GM animals intended for food use.
Toxins
Some foods contain low-level toxic agents that may be
protein, glycoproteins or protein fragments released by diges-
tion. The content of these molecules may be reduced by
traditional cooking practices; for example, soaking of leg-
umes. Favism is a condition produced in individuals with a
congenital deficiency of glucose-6-phosphatase that results
in a haemolytic anaemia after consuming fava (broad) beans.
Lectins (haemagglutinins) are present in a wide range of
legumes. Red kidney beans, for example, are quite toxic if
eaten uncooked.44 There is a large potential for improving
the nutritional characteristics of the many legume species by
gene manipulation.
High-protein moist protein foods such as meat, egg and
milk products are prone to bacterial contamination and the
development of dangerous toxins if not treated correctly.
There are many incidents each year in which inadequate
hygiene, food handling procedures, cooking, refrigeration
etc. result in food poisoning. The hazard analysis critical
control point (HACCP) approach is particularly important in
preventing spoilage and food poisoning. There are numerous
bacterial toxins involved in food poisoning, some of which
are heat stable (e.g. Staphylococcus toxin). Food-preserving
standards are based on criteria designed to prevent survival
of the most heat-resistant bacteria and toxins. Periodically
new food poisoning outbreaks occur that force a revision of
the criteria. A number of outbreaks of food poisoning
following consumption of hamburger meat and fermented
sausage contaminated with Escherichia coli strain O157 in
recent years brought the haemolytic uremic syndrome into
prominence, resulting in a revision of procedures for the safe
handling of minced meats.
Fermentations have a long history of use in food preser-
vation in developing countries but also involve some degree
of risk. Wherever fermented protein foods are made it is
important that the operators know and use the correct
conditions required to produce a safe product. Poorly con-
trolled bacterial fermentation of meat can result in botulism,
which can be fatal. Fermentations with fungi can also pose
hazards; many fungi produce toxins, not all of which have
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been characterized. Toxins such as aflatoxin produced by
Aspergillus flavus in mould-infested food can cause liver
damage and ultimately lead to liver cancer. The food of most
concern has been peanut crops in Africa but a variety of
foods can be affected. Sensitive techniques are now used to
monitor peanuts for aflatoxin content. Several samples of
peanuts destined for human consumption in the UK were
recently found to contain aflatoxin content above the EU
limit of 2 µg per kg.45
Fish toxins can be particularly potent. Ciguatera is a toxin
occurring in fish is tropical waters and is apparently carried
up the food chain from a dinoflagellate bloom. Consuming
affected fish leads to gastrointestinal and particularly neuro-
logical symptoms, including inverse temperature perception,
and in rare severe cases, convulsions, paralysis and death.
Usually recovery occurs over a few days although neuro-
logical symptoms can linger on for months. The illness may
be more severe if previously affected individuals again
consume toxic fish. Many people are affected in tropical
regions each year. Unfortunately there is as yet no simple
test that will identify toxic fish. Most bulk fish industries
draw their fish from relatively cold waters but as developing
tropical countries increase their processed fish industries this
type of fish poisoning may become more important.
Scombroid fish poisoning can occur if partially spoiled
fish such as anchovies, mackerel or tuna, are consumed; the
effects are caused by ingestion of pharmacologically active
quantities of histamine released by microbial decarboxyl-
ation of histidine in the fish flesh. In scombroid fish poison-
ing, histamine produces flushing, sweating, rash, nausea,
diarrhoea, and headache. Typically the onset and duration of
the illness are short, and the severity of the symptoms varies
according to the individual’s sensitivity to histamine. Other
amines such as putrescine and cadaverine formed by decar-
boxylation of ornithine and lysine may act synergistically by
inhibiting the histamine detoxifying enzymes, diamine
oxidase and histamine N-methyl transferase.46 The reaction
is not an allergy and all individuals will react to some degree
to contaminated fish. One organism, Morganella morganii,
appears to be of particular importance in generating hista-
mine in spoiled fish. Rapid and efficient handling of fish
with appropriate refrigeration is necessary to avoid scom-
broid poisoning. Fish are an important source of high-quality
protein in developing countries and greater use of fish is to
be encouraged, not least because of the contribution to iodine
supply. It is important then to encourage the development of
refrigeration technology for handling foods susceptible to
spoilage. Under new FDA guidelines, fishery products con-
taining histamine at more than 5 mg/g fish are subject to
rejection or recall.47
Education
Often in developing communities, the resources are available
for the production of foods that would eliminate nutrition
problems such as protein–energy malnutrition in children,
but there is a lack of knowledge regarding infant and toddler
nutritional needs and the foods that will meet those needs. A
simple example is the use of more eggs and meat and less use
of bulky cereals and root crops as weaning foods. In this
context it is important that education resources should be
equally accessible to women as to men. There may also be
lack of knowledge of relatively simple farming methods that
would produce sufficient appropriate foods to overcome
particular malnutrition problems, for example, growing
chickens for eggs and meat. Education therefore remains one
of the most important aspects of improvement in diets with
regard to adequacy of protein supply. However, it is also
worth bearing in mind that knowledge does not necessarily
change behaviour and other strategies to change behaviour
may need to be adopted.
In developed countries, literacy and education are at
higher levels but it is still difficult to give prominence to
basic nutrition information. One of the risks posed by a
rising tide of health claims relating to novel food products is
that basic information on sensible nutrition practices for the
maintenance of health will become submerged in a sea of
advertising promulgated by vested interests. Responsible
authorities will need to continue funding for basic education
on nutrition and health.
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